TNF-α, a pleiotropic cytokine produced by activated macrophages, T cells,and natural killer cells, is among the most important immune responseregulators; therefore, affecting the level of this cytokine can be an efficientstrategy for correcting immune disorders associated with cancer, as well asinflammatory, metabolic, and infectious diseases [38, 39]. The gene discussed is TNF; the disease is cancer.